Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-29

FDA Approved: LEFLUNOMIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved an original-application generic for Leflunomide from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

ORIG AP for LEFLUNOMIDE (LEFLUNOMIDE)